Oculis announces publication of Phase 2 data showing topical eye drops anti-TNFa agent licaminlimab (OCS-02) relieves persistent ocular discomfort in severe dry eye disease
LAUSANNE, Switzerland, Aug 23, […]
IND Application for SinoMab’s First-in-Class Asthma Therapeutic Product SM17 Approved by FDA
HONG KONG, Mar 14, 2022 – […]
New treatment for severe corneal inflammation from DED now listed on PBS
MELBOURNE, Oct 1, 2021 – […]
Regeneron Pharmaceutical’s Covid-19 antibody cocktail likely be used in Singapore once available
SINGAPORE – Regeneron Ph […]